StockNews.com Downgrades Catalyst Pharmaceuticals (NASDAQ:CPRX) to Buy
StockNews.com downgraded shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Free Report) from a strong-buy rating to a buy ...
HC Wainwright Issues Positive Forecast for Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock Price
Catalyst Pharmaceuticals (NASDAQ:CPRX – Get Free Report) had its price target raised by HC Wainwright from $30.00 to $35.00 ...
Buy Rating Maintained for Apellis Pharmaceuticals: Strategic Market Position and Growth Potential Justify Price Objective
Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Apellis Pharmaceuticals (APLS – Research Report) yesterday and set a ...
air cargo10h
Can technology solve biggest inefficiencies in global supply chains?
With the emergence of AI, IoT, predictive tools and advanced tech platforms, airlines, airports and retail giants can ...
N-Power Medicine Acquires Syapse to Expand Its Next-Generation Community-Based Network for Oncology Clinical Research and Clinical Trials
Power Medicine, a company leading the reinvention of the clinical trial process, today announced the acquisition of Syapse ...
Rugbypass18h
Rugby News
Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...